. Author manuscript; available in PMC: 2019 Dec 1.

Published in final edited form as: Dis Colon Rectum. 2018 Dec;61(12):1350–1356. doi: 10.1097/DCR.0000000000001219

Table 2.

Patients with AIN III who were diagnosed with other primary neoplasms.

Type of other primary neoplasm	Before first AIN III diagnosis N (%)	After first AIN III diagnosis N (%)

Any other primary neoplasm	935 (45.1%)	912 (44.0%)

Any other HPV-related tumor	343 (16.5%)	323 (15.6%)
Anal carcinoma	n/a	171 (8.2%)
Cervical neoplasm	55 (2.7%)	2 (0.1%)
Oropharyngeal malignancy	15 (0.7%)	22 (1.1%)
Penile malignancy	5 (0.2%)	6 (0.3%)
Vaginal malignancy	27 (1.3%)	10 (0.5%)
Vulvar malignancy	278 (13.4%)	117 (5.6%)

Any AIDS-defining malignancy	262 (12.6%)	56 (2.7%)
Kaposi sarcoma	172 (8.3%)	24 (1.2%)
Non-Hodgkin lymphoma	89 (4.3%)	30 (1.4%)
Cervical cancer	8 (0.4%)	2 (0.1%)

AIN: anal intraepithelial neoplasia; HPV: human papillomavirus; AIDS: acquired immune deficiency syndrome